GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » Other Operating Expense

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Other Operating Expense

: $-37 Mil (TTM As of Dec. 2023)
View and export this data going back to 2001. Start your Free Trial

Dr Reddy's Laboratories's Other Operating Expense for the three months ended in Dec. 2023 was $-6 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-37 Mil.

Dr Reddy's Laboratories's quarterly Other Operating Expense declined from Jun. 2023 ($-9 Mil) to Sep. 2023 ($-16 Mil) but then increased from Sep. 2023 ($-16 Mil) to Dec. 2023 ($-6 Mil).

Dr Reddy's Laboratories's annual Other Operating Expense declined from Mar. 2021 ($-14 Mil) to Mar. 2022 ($-22 Mil) and declined from Mar. 2022 ($-22 Mil) to Mar. 2023 ($-87 Mil).


Dr Reddy's Laboratories Other Operating Expense Historical Data

The historical data trend for Dr Reddy's Laboratories's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Operating Expense
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.94 -57.68 -14.06 -21.55 -86.52

Dr Reddy's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.30 -5.11 -9.39 -16.36 -5.96

Dr Reddy's Laboratories Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Reddy's Laboratories Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Headlines